Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
Wang
Yanwen
Y
Institute for Nutrisciences and Health, National Research Council Canada, Charlottetown, Prince Edward Island, Canada. yanwen.wang@nrc.ca
Campbell
Tony
T
Perry
Benjamin
B
Beaurepaire
Cécile
C
Qin
Ling
L
D052242:Adiponectin / Q000097:blood; D000818:Animals; D001599:Berberine / Q000627:therapeutic use*; D001786:Blood Glucose / Q000187:drug effects; D002097:C-Reactive Protein / Q000032:analysis; D002784:Cholesterol / Q000008:administration & dosage; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004041:Dietary Fats / Q000008:administration & dosage*; D005951:Glucose Tolerance Test; D005978:Glutathione / Q000032:analysis; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance / Q000502:physiology*; D020738:Leptin / Q000097:blood; D008099:Liver / Q000737:chemistry / Q000187:drug effects / Q000201:enzymology; D008297:Male; D008315:Malondialdehyde / Q000032:analysis; D018384:Oxidative Stress / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D013482:Superoxide Dismutase / Q000032:analysis; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
D052242:Adiponectin; D001786:Blood Glucose; D004041:Dietary Fats; D007004:Hypoglycemic Agents; D007328:Insulin; D020738:Leptin; D014409:Tumor Necrosis Factor-alpha; D001599:Berberine; D008315:Malondialdehyde; D002097:C-Reactive Protein; D002784:Cholesterol; D013482:Superoxide Dismutase; D005978:Glutathione